Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT05319873 |
| Title | Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Jonsson Comprehensive Cancer Center |
| Indications | |
| Therapies |
Carboplatin + Docetaxel + Pertuzumab + Trastuzumab |
| Age Groups: | adult | senior |
| Covered Countries | USA |